Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, Lin J-R, Dillon DA, Pathania S, Sorger PK, Mills GB, Brugge JS.
Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proceedings of the National Academy of Sciences. 2020;117 (28) :16500-16508.
Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E.
The Human Tumor Atlas Network: charting tumor transitions across space and time at single-cell resolution. Cell. 2020;181 (2) :236-249.
Hemming ML, Nathenson MJ, Lin J-R, Mei S, Du Z, Malik K, Marino-Enriquez A, Jagannathan JP, Sorger PK, Bertagnolli M.
Response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of NTRK1. JCO precision oncology. 2020;4.
Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su M-J, Shah P.
A single-cell landscape of high-grade serous ovarian cancer. Nature Medicine. 2020;26 (8) :1271-1279.